ConductScience.org, home

Paper40402425

Sentinel Lymph Node Mapping in Esophageal Cancer: Current Status and Future Directions.

Chopko TC and 3 others. Ann Surg Oncol, 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Sentinel Lymph Node Mapping in Esophageal Cancer: Current Status and Future Directions. Papers, record 40402425. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40402425

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Sentinel Lymph Node Mapping in Esophageal Cancer: Current Status and Future Directions.
PubMed
Journal
Ann Surg Oncol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2025-11-06
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chopko TCTrevor C
2Maroun JWJustin W
3Reisenauer JSJanani S
4Tapias LFLuis F

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Esophageal NeoplasmsMajor topic
Sentinel Lymph NodeMajor topic
Sentinel Lymph Node BiopsyMajor topic
Humans
Lymph Node Excision
Prognosis
Lymphatic Metastasis
Esophagectomy

Source PubMed

Download CSV of topics

References68

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
219036143Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS).BMC Surg2008https://conductscience.org/library/papers/19036143PubMed
326254683Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.Lancet Oncol2015https://conductscience.org/library/papers/26254683PubMed
433891478Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial.J Clin Oncol2021https://conductscience.org/library/papers/33891478PubMed
519392846The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma.Dis Esophagus2010https://conductscience.org/library/papers/19392846PubMed
614566257Extracapsular lymph node involvement is a negative prognostic factor in T3 adenocarcinoma of the distal esophagus and gastroesophageal junction.J Thorac Cardiovasc Surg2003https://conductscience.org/library/papers/14566257PubMed
718216546
The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent.
Ann Surg2008https://conductscience.org/library/papers/18216546PubMed
831188203Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis.Ann Surg2020https://conductscience.org/library/papers/31188203PubMed
932519142Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach?Ann Surg Oncol2020https://conductscience.org/library/papers/32519142PubMed
1030903323Differences in Esophageal Cancer Surgery in Terms of Surgical Approach and Extent of Lymphadenectomy: Findings of an International Survey.Ann Surg Oncol2019https://conductscience.org/library/papers/30903323PubMed
1135689575Two- versus three-field lymphadenectomy for esophageal cancer. A systematic review and meta-analysis of early and late results.J Surg Oncol2022https://conductscience.org/library/papers/35689575PubMed
1239080133The Impact of D2 Versus D1 Lymphadenectomy in Siewert II Gastroesophageal Junction (GEJ) Cancer.Ann Surg Oncol2024https://conductscience.org/library/papers/39080133PubMed
1311573045Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies.Ann Surg2001https://conductscience.org/library/papers/11573045PubMed
1433551083Esophageal Cancer: Tumor-Node-Metastasis Staging.Radiol Clin North Am2021https://conductscience.org/library/papers/33551083PubMed
1520189259Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: A report of 1077 cases.Radiother Oncol2010https://conductscience.org/library/papers/20189259PubMed
1620971285Prognostic relevance of skip metastases in esophageal cancer.Ann Thorac Surg2010https://conductscience.org/library/papers/20971285PubMed
1737015332Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2023https://conductscience.org/library/papers/37015332PubMed
1834544603Three-field versus two-field lymphadenectomy for esophageal squamous cell carcinoma: A long-term survival meta-analysis.Surgery2022https://conductscience.org/library/papers/34544603PubMed
1925548502Three-field vs two-field lymph node dissection for esophageal cancer: a meta-analysis.World J Gastroenterol2014https://conductscience.org/library/papers/25548502PubMed
2030119872Operative time in esophagectomy: Does it affect outcomes?Surgery2018https://conductscience.org/library/papers/30119872PubMed

See all 68 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42731004Sentinel Node Navigation Surgery for Upper Gastrointestinal Malignancies: Current Status, Clinical Significance, and Future Perspectives.Magy Onkol2026https://conductscience.org/library/papers/42731004PubMed
42374006Reconsidering the Value of Lymphadenectomy in Esophageal Squamous Cell Carcinoma in the Setting of Neoadjuvant Immunotherapy: Insights from a Multicenter Retrospective Study.Ann Surg Oncol2026https://conductscience.org/library/papers/42374006PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
NODAL4838PubTator's text mininghttps://conductscience.org/library/genes/4838

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40402425

GET https://conductscience.org/api/papers/v1/40402425/references?page=2